DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Meprobamate (Meprobamate) - Summary

 
 



MEPROBAMATE SUMMARY

Meprobamate is a white powder with a characteristic odor and a bitter taste. It is slightly soluble in water, freely soluble in acetone and alcohol, and sparingly soluble in ether.

Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.

The effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.


See all Meprobamate indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Meprobamate

Largest study of Hispanics/Latinos finds depression and anxiety rates vary widely among groups
Source: Anxiety / Stress News From Medical News Today [2014.10.25]
Rates of depression and anxiety vary widely among different segments of the U.S.

Animal therapy reduces anxiety, loneliness symptoms in college students
Source: Anxiety / Stress News From Medical News Today [2014.10.24]
Animal-assisted therapy can reduce symptoms of anxiety and loneliness among college students, according to researchers at Georgia State University, Idaho State University and Savannah College of...

I have anxiety, why is my doctor prescribing an antipsychotic? New drug naming system unveiled
Source: Pharma Industry / Biotech Industry News From Medical News Today [2014.10.21]
What's in a name? Doctors have found that the name of the drug you are prescribed significantly influences how the patient sees the treatment.

Ebola Anxiety: A Bigger Threat Now Than the Virus Itself
Source: MedicineNet Headache Specialty [2014.10.21]
Title: Ebola Anxiety: A Bigger Threat Now Than the Virus Itself
Category: Health News
Created: 10/21/2014 12:00:00 AM
Last Editorial Review: 10/21/2014 12:00:00 AM

Heightened risk of anxiety, depression among women after heart attack
Source: Anxiety / Stress News From Medical News Today [2014.10.20]
Following a heart attack, women are more likely to develop anxiety and depression than men, claim researchers. They also say depression after a heart attack raises risk of death.

more news >>

Published Studies Related to Meprobamate

Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. [2003.06]
Implementation of regulations to control the prescribing of benzodiazepines in New York State in 1989 resulted in a 55% decrease in benzodiazepine prescribing, with a concomitant increase in the rates of prescribing older sedative-hypnotic compounds such as butabarbital (30% increase) and meprobamate (125% increase).

more studies >>

Reports of Suspected Meprobamate Side Effects

Toxicity TO Various Agents (28)Respiratory Arrest (15)Cardiac Arrest (15)Accidental Death (14)Drug Abuse (11)Completed Suicide (11)Death (5)Multiple Drug Overdose Accidental (5)Pulmonary Congestion (5)Pulmonary Oedema (4)more >>


Page last updated: 2014-10-25

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014